Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder
Clinical trial NCT06261060 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06261060
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-20
- Primary completion
- 2028-06-11
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.